Disclosure Of First-Time Adoption [Text Block]

Captor Therapeutics S.A. - Filing #6216905

Concept As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
58 208 PLN
175,000 PLN
124 201 PLN
124 201 PLN
170 031 PLN
11 779 PLN
11,000 PLN
413,000 PLN
7,000 PLN
359,000 PLN
1 004 PLN
25 636 PLN
5 690 PLN
16 292 PLN
1 004 PLN
2 284 PLN
25,636,000 PLN
1,004,000 PLN
359,000 PLN
7,000 PLN
5 690 PLN
16,292,000 PLN
2,284,000 PLN
1 004 PLN
550,000 PLN
359,000 PLN
18,000 PLN
12 942 PLN
4 277 PLN
16 292 PLN
4 277 PLN
Comprehensive income
38,000 PLN
32 530 PLN
4,000 PLN
32 530 PLN
32 572 PLN
12 652 PLN
12 694 PLN
35,000 PLN
7,000 PLN
12 652 PLN
Profit (loss)
32 572 PLN
32 572 PLN
32 572 PLN
12 694 PLN
12 694 PLN
12 694 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.